Stock 688212 SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai AoHua Photoelectricity Endoscope Co., Ltd.

Equities

688212

CNE100004ZJ5

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
53.41 CNY -5.72% Intraday chart for Shanghai AoHua Photoelectricity Endoscope Co., Ltd. +4.85% -13.90%
29/04 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
26/02 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's profit outlook over the next few years is a strong asset.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 70.28 times its estimated earnings per share for the ongoing year.
  • The company appears highly valued given the size of its balance sheet.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-13.90% 989M -
SARTORIUS AG Stock Sartorius AG
-15.28% 18.56B
A
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-46.16% 2.71B
C+
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+17.00% 1.85B - -
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-0.51% 1.66B -
BIOTAGE AB Stock Biotage AB
+25.65% 1.22B
B+
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-21.76% 896M -
C-
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-19.12% 660M
B+
CELLAVISION AB Stock CellaVision AB
+6.37% 490M
C+
PHC CO.,LTD. Stock PHC Co.,Ltd.
-.--% 300M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 688212 Stock
  4. Ratings Shanghai AoHua Photoelectricity Endoscope Co., Ltd.